Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Transcept Pharmaceuticals Rises on Potential Sleeping Pill Approval
Minyanville
Tuesday, October 4, 2011 - 1:35pm
tags:
Transcept, insomnia, Intermezzo
1 Reason the Street Should Love Gilead Sciences' Earnings
Motley Fool
Tuesday, October 4, 2011 - 1:33pm
tags:
Gilead, earnings
Nektar Bulls Fight Through Pain
TheStreet.com
Tuesday, October 4, 2011 - 1:32pm
tags:
Nektar
Spanish Drugmakers Eye $7 Billion Sale of Bonds Backed by Unpaid Bills
Bloomberg
Tuesday, October 4, 2011 - 1:30pm
tags:
Spain, Novartis, Roche
Biotech Busts And Breakthroughs For September 2011
Forbes
Tuesday, October 4, 2011 - 12:32pm
tags:
Pacific Biosciences, Lexicon Pharmaceuticals, China Pharmaceutical, Momenta, SYNERGY, Caliper Life Sciences, Optimer, MannKind, Pharmasset, Hi-Tech Pharmacal
5 Biotech Stocks Seeing Significant Short Covering
Seeking Alpha
Tuesday, October 4, 2011 - 12:28pm
tags:
Biocryst, BioDelivery Sciences, Cephalon, Biomarin, Immunogen
Contraceptive Injections Double HIV Infection Risk in Study
Bloomberg
Tuesday, October 4, 2011 - 12:22pm
tags:
HIV, Depo Provera, contraceptives
Somaxon Reports Positive FDA Feedback On Silenor OTC Pathway; Stock Surges 37%
RTT News
Tuesday, October 4, 2011 - 12:20pm
tags:
Somaxon, OTC, Silenor, FDA, insomnia
Why Contract Research Organizations Are Hot
Pharmalot
Tuesday, October 4, 2011 - 12:18pm
tags:
CROs
Pfizer Signs Saudi Arabia Pharmaceutical Plant Deal, SPA Says
Bloomberg
Tuesday, October 4, 2011 - 12:16pm
tags:
Pfizer, Saudi Arabia
Bristol-Myers Plans to Continue Growing Company, Chief Says
Bloomberg
Tuesday, October 4, 2011 - 12:16pm
tags:
Bristol-Myers Squibb, Pharma CEOs, Lamberto Andreotti
Santarus Plans NDA Filing On Key New Drug
Seeking Alpha
Tuesday, October 4, 2011 - 11:25am
tags:
Santarus, Budesonide MMX, ulcerative colitis
Dapagliflozin And Libigel Lead 4 October Healthcare Catalysts
Seeking Alpha
Tuesday, October 4, 2011 - 11:23am
tags:
LibiGel, Dapagliflozin, Antares, AstraZeneca, BioSante, Bristol-Myers Squibb, Teva Pharmaceuticals, Pacira
Dendreon Revisited: What Management Is Saying About Provenge
Seeking Alpha
Tuesday, October 4, 2011 - 10:44am
tags:
Dendreon, prostate cancer, Provenge
Merck Wins A Bellwether Fosamax Trial
Pharmalot
Monday, October 3, 2011 - 12:39pm
tags:
Fosamax, Merck
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Monday, October 3, 2011 - 12:37pm
tags:
Achillion, Aeterna Zentaris, Antigenics, Ariad, Amylin, Amarin, BioDelivery Sciences, Cyclacel, Geron, Dendreon, PharmAthene, Zalicus, Human Genome Sciences, Keryx, Peregrine Pharmaceuticals, SIGA technologies, YM BioSciences
Medicines Co. rises after settling lawsuit with Teva over generic version of its drug Angiomax
Yahoo/AP
Monday, October 3, 2011 - 12:33pm
tags:
generics, Angiomax, Medicines Company, anticlotting, Teva Pharmaceuticals
Galapagos inks $367M deal in back-ended discovery pact with Servier
Fierce Biotech
Monday, October 3, 2011 - 11:46am
tags:
Servier, Galapagos
EntreMed shares spike on PhII cancer data
Fierce Biotech
Monday, October 3, 2011 - 11:42am
tags:
EntreMed, ENMD-2076, ovarian cancer
Micromet Maxes Out These 2 Metrics
Motley Fool
Monday, October 3, 2011 - 11:40am
tags:
Micromet

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.